Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34cdc2

被引:13
作者
Ababneh, M [1 ]
Götz, C [1 ]
Montenarh, M [1 ]
机构
[1] Univ Saarlandes, D-66421 Homburg, Germany
关键词
cyclin-dependent kinase p34(cdc2); p53; growth suppressor protein; protein-protein interaction; phosphorylation;
D O I
10.1006/bbrc.2001.4792
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously found that p53 binds to the catalytic subunit of the p34(cdc2)/cyclin B1-kinase. In the present study we analyzed the functional consequences of this interaction. Binding of wild-type p53 to p34(cdc2)/cyclin B1 results in a significant decrease of its histone H1 kinase activity. Binding of p53 to the kinase is a prerequisite for the inhibition because a mutant p53 which lacks the binding region fails to influence the enzymatic activity. Furthermore, by using C-terminal fragments of p53 it became obvious that also some other structural elements in the N-terminal region are necessary for the inhibitory effect. Our present study provides evidence that p53 might regulate cell-cycle checkpoints not only on the transcriptional level but also by binding to the cell-cycle regulating kinase p34(cdc2) (C) 2001 Academic Press.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 39 条
[1]  
Azzam EI, 1997, CELL GROWTH DIFFER, V8, P1161
[2]   HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2 [J].
BISCHOFF, JR ;
FRIEDMAN, PN ;
MARSHAK, DR ;
PRIVES, C ;
BEACH, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4766-4770
[3]   Assessment of SNRPN expression as a molecular tool in the diagnosis of Prader-Willi syndrome [J].
Carrel, AL ;
Huber, S ;
Allen, DB ;
Voelkerding, KV .
MOLECULAR DIAGNOSIS, 1999, 4 (01) :5-10
[4]   14-3-3σ is required to prevent mitotic catastrophe after DNA damage [J].
Chan, TA ;
Hermeking, H ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1999, 401 (6753) :616-620
[5]  
de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887
[6]   The in vitro phosphorylation of p53 by calcium-dependent protein kinase C - Characterization of a protein-kinase-C-binding site on p53 [J].
Delphin, C ;
Huang, KP ;
Scotto, C ;
Chapel, A ;
Vincon, M ;
Chambaz, E ;
Garin, J ;
Baudier, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (03) :684-692
[7]  
El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121
[8]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[9]  
Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138
[10]   Protein kinase CK2 interacts with a multi-protein binding domain of p53 [J].
Götz, C ;
Scholtes, P ;
Prowald, A ;
Schuster, N ;
Nastainczyk, W ;
Montenarh, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 191 (1-2) :111-120